Bản sao của OSCE NỘI
Complications of COPD
SHH, TKMP, and Atelectasis
Complications include pressure pneumothorax and significant pleural effusion (TKMP), leading to midline shift of the mediastinum.
Hemodynamic instability often occurs, typically causing hypotension.
Pleural Disease
Causes of acute left chest pain include the "4 TIM":
Myocardial Infarction (MI)
Aortic Dissection
Acute Pericarditis
Cardiac Tamponade
Pulmonary causes include TKMP or pulmonary embolism.
Gastrointestinal causes such as esophageal rupture.
Treatment for Acute COPD Exacerbation
Hospitalization
Intensive care unit (ICU) admission and level 1 monitoring.
Oxygen Therapy
Maintain SpO2 between 88-92% using a cannula.
Bronchodilators
Administer bronchodilators.
Systemic Corticosteroids
For example, Methylprednisolone (Medrol) 16mg twice daily or 40mg once daily.
Special Case of Acute COPD with TKMP:
Hospitalization
Level 1 monitoring.
Oxygen Therapy
Administration via cannula at 3L/min to maintain SpO2 88-92%.
Medications
Combivent (Ipratropium/Salbutamol) at dosage of 0.5mg in 2.5ml.
Non-Pharmacological Treatment for COPD
General Maintenance
Avoid dusty environments and quit smoking.
Vaccinations for influenza, pneumococcus, pertussis (if not vaccinated in childhood), and varicella (above 50 years), and COVID-19.
Physical therapy and exercise.
Specific Treatment for Uncontrolled Asthma With Future Risks
Monitor adherence to treatment.
Educate the patient on correct usage of inhalers.
Escalate treatment if the patient adheres but still remains uncontrolled. For example:
Use of Albuterol and Fluticasone combination.
Light's Criteria for Pleural Effusion Analysis
Light's Criteria Evaluation
Protein ratio of pleural fluid to serum protein: 48.4/60 > 0.5 (2 points)
LDH ratio of pleural fluid to serum: 1950/203 > 0.6 (1 point)
Pleural LDH > 2.5 times upper limit of normal for serum. Each point confirmed leads to exudative pleural effusion diagnosis.
Treatment of Exudative Pleural Effusion
Hospitalization
General ward, level 3 care.
Oxygen Supplementation
Cannula at 2L/min ensuring SpO2 ≥ 95% (in this case of no SHH).
Antibiotic Therapy
Minimum 5 days of Levofloxacin at 750mg once daily.
Diagnostic Imaging for Pleural Effusion
Technique
AP film taken with full inspiration, adequate exposure.
Ensure soft tissue is not compromised, no subdiaphragmatic free air under ribs.
Assess ribs for fractures or cracks; look for homogeneous opacity of left lung pushing the mediastinum right.
Characteristics of Pleural Exudate
Dark red effusion with blood clots indicates vascular involvement.
Pleural fluid analysis such as protein, LDH, and ratios indicating exudate versus transudate.
Evaluation of Asthma Control
Symptoms Frequency
Daytime asthma symptoms more than 2 times a week?
Nocturnal Symptoms
Awakenings at night due to asthma?
Reliever Use
Use of rescue inhalers more than 2 times a week?
Activities Limitations
Any activity limitations due to asthma symptoms?
Differential Diagnosis of COPD
List possible future risk factors for asthma in patients:
Uncontrolled asthma
Obesity
Gastroesophageal reflux disease (GERD)
Smoking
Food allergies
Specific In-hospital Treatment Orders
Antibiotics: Administer with signs of infection (fever, purulent sputum, imaging abnormalities).
Oxygen: Maintain SpO2 between 93%-95%.
Sedation: Avoid in acute asthma attacks as it suppresses respiratory drive.
Clinical Laboratory Orders for Pneumonia Diagnosis
Blood gas analysis
Chest X-ray
Serum Urea levels
Complete Blood Count (CBC) with differential.
Severity Classification of Pneumonia (by ATS/IDSA 2007)
Classifications, especially in sepsis, might need vascular support and respiratory failure interventions.
Initial Management of COPD Exacerbation
Management Pathway for COPD and Pneumonia
Follow the CURB-65 protocol for pneumonia severity.
Management based on patient presentation and clinical guidelines.
Conclusion
Continuous monitoring and reassessment for both COPD and asthma patients are crucial for effective treatment and management.